Results 31 to 40 of about 4,880,466 (235)

Publication bias.

, 2022
Publication bias.
Jianhua Zou (766577), Kangjun Yi (13822700), Tengteng Hao (13777483), Yu Wu (54264), Zhongyu Li (85501), Jingyan Yang (7120994), Ning Cui (502137), Liusheng Li (13777480), Jiao Wu (446887)   +8 more
core   +2 more sources

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann, Maike Wellbrock, Javier Louro, Arndt Borkhardt, Martin Schrappe, Claudia Trübenbach, Desiree Grabow, Cécile M. Ronckers, Joachim Schüz   +8 more
wiley   +1 more source

Publication pressure versus scientific integrity

Journal of Integrative Medicine and Research
The scientific community is aware of the issue of publication pressure. While scientific authors frequently discuss the topic, it is not equally addressed at all levels within the scientific hierarchy.
Geeta Chand Acharya
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Riesgo de sesgo de publicación en intervenciones terapéuticas para la COVID-19

Revista Panamericana de Salud Pública, 2021
This article describes publication bias, its most frequent causes, its characteristics, the regulatory tools to avoid it, and some statistical techniques to analyze it. These techniques are explained and applied to three therapeutic interventions related
Santiago Hasdeu, Fernando Tortosa
doaj   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Local model uncertainty and incomplete-data bias (with discussion) [PDF]

, 2005
Problems of the analysis of data with incomplete observations are all too familiar in statistics. They are doubly difficult if we are also uncertain about the choice of model.
Barry, Sarah, Recchia, Angela, Sharif, Maarya,, Copas, John,, Conte, Rossella Lo, Skinner, Chris J., Eguchi, Shinto, Parker, Helen,, Onabid, Mathias, Purutçuoğlu, Vilda, Wit, Ernst,, Weir, James, McGrory, Clare, Nguyen, The Mahn,, Wit, Ernst, Pritchard, Gareth, Miller, James, Zhu, Ximin, Conte, Rossella Lo,, Henderson, Neil, Ferguson, Claire, Pritchard, Gareth,, Zhu, Ximin,, Copas, John, Parker, Helen, Barry, Sarah,, John Copas, Weir, James,, Eguchi, Shinto,, Purutçuoğlu, Vilda,, Shinto Eguchi, Fearnside, Alastair, Fearnside, Alastair,, McGrory, Clare,, Ferguson, Claire,, Sharif, Maarya, Onabid, Mathias,, Miller, James,, Nguyen, The Mahn, Recchia, Angela,, Henderson, Neil,   +40 more
core   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

Publication bias.

, 2021
Publication bias.
Tim De Jong (11785190), Carlijn R. Hooijmans (7321292), Caroline A. Hundepool (11785184), Berend O. Broeren (11785178), J. Michiel Zuidam (11785187), Erik T. Walbeehm (10488112), Liron S. Duraku (11785181)   +6 more
core   +1 more source